Lexicon Pharmaceuticals | Custo De Mercadoria Vendida

Preço das Ações
1.31
Mudança Diária
-0.01 -0.38%
Mensal
10.59%
Anual
87.77%
Q1 Previsão
2.01




Custo de Mercadoria Vendida Alterar Data
Abbott USD 4.92B 535M 2025-12
Acadia Pharmaceuticals USD 21.65M 913K 2025-09
Agios Pharmaceuticals USD 1.68M 22K 2025-09
Akebia Therapeutics USD 8.13M 2.41M 2025-03
Alnylam Pharmaceuticals USD 200.15M 57.2M 2025-09
AstraZeneca USD 3.27B 471M 2025-12
BioMarin Pharmaceutical USD 144.93M 10M 2025-09
Coherus Biosciences USD 2.65M 31.2M 2025-03
Eli Lilly USD 3.37B 363.7M 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Halozyme Therapeutics USD 73M 8.88M 2025-09
Illumina USD 400M 49M 2025-12
Insmed USD 30.9M 1.56M 2025-09
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
J&J USD 7.97B 689M 2025-12
Lexicon Pharmaceuticals USD 17.81M 3.41M 2024-06
MacroGenics USD 44.3M 5.4M 2025-09
MannKind USD 20.2M 365K 2025-09
Merck USD 3.32B 531M 2025-12
Moderna USD 207M 88M 2025-09
Novartis USD 3.54B 217M 2025-09
PTC Therapeutics USD 23.32M 7.83M 2025-09
Puma Biotechnology USD 29.1M 18.44M 2024-09
Sarepta Therapeutics USD 151.45M 1.77M 2025-09
Thermo Fisher Scientific USD 7.58B 674M 2025-12
Ultragenyx Pharmaceutical USD 27.99M 4.99M 2025-09
United Therapeutics USD 100.9M 74.3M 2025-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12


Lexicon Pharmaceuticals Custo De Mercadoria Vendida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.